Efficient immunity against Leishmania major in the absence of interleukin-6

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2448-2450

  Moskowitz, Naomi H ^a   Brown, Daniel R ^a   Reiner, Steven L ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HOST RESISTANCE; INFECTION RESISTANCE; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030955851     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.6.2448-2450.1997     Document Type: Article

References (24)

1. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Funslow, S. G. Reed, and C. R. Maliszewski. 1996. CD4 ligand is required for protective cellmediated immunity to Leishmania major. Immunity 4:283-289.
2. Chakkalath, H. R., C. M. Theodas, J. S. Murkowitz, M. J. Grusby, L. H. Glimeher, and R. G. Titus. 1995. Class II major histocompatibility complex- deficient mice initially control an infection with Leishmania major but succumb to the disease, J. Infect. Dis. 171:1302-1308.
3. Conlan, J. W., and R. J. North. 1994. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granuloeyte-depleting monoclonal antibody. J. Exp. Med. 179:259-268.
4. Czuprynski, C. J., J. K. Brown, N. Maroushek, R. D. Wagner, and H. Steinberg. 1994. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol. 152:1 836-1846.
5. Dalrymple, S. A., L. A. Lucian, R. Slattery, T. McNeil, D. M. Aud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63:2262-2268.
6. Durum, S. K., and J. J. Oppenheim. 1993. Proinflammatory cytokines and immunity, p. 801-836. In W. E. Paul (ed.), Fundamental immunology. Raven Press. New York, N.Y.
7. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required for the protective immune response against Mycobucterium tubercuulosis in mice. Immunity 2:561-572.
8. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115-6119.
9. Hatzigeorgiou, D. E., S. He, J. Sobel, K. H. Grabstein, A. Hafner, and J. L. Ho. 1993. IL-6 down-modulates the cytokinc-enhanced antileishmanial activity in human macrophages. J. Immunol. 151:3682-3692.
10. Heinzel, F. P., R. M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730-739.
11. Kamanaka, M., P. Yu, T. Yasui, K. Yoshidi, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275-281.
12. Kopf, M., H. Buumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342.
13. Locksley, R. M., S. L. Reiner, F. Hatam, D. R. Littman, and N. Killeen. 1993. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261:1448-1451.
14. Pfeffer, K., T. Mutsuyama, M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Weignmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55-kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
15. Reiner, S. L., and R. M. Locksley. 1947. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
16. Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1943. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165:37-46.
17. Romani, L., A. Mencacci, E. Cenci, R. Spuccapelo, C. Toniatti, P. Puccetti, F. Bistoni, and V. Poli. 1996. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin-6-deficieni mice infected with Candida albicans. J. Exp. Med. 183:1345-1355.
18. Rothe, J., W. Lesslauer, H. Loetscher, Y. Lang, P. Koebel, F. Koentgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Blucthmann. 1493. Mice lucking the tumor necrosis receptor 1 are resistant to TNF-mediatcd toxicity hut highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
19. Scharton, T. M., and P. Scott. 1943, Natural killer cells are a source of inerferon-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmunia major in mice. J. Exp. Med. 170:567-577.
20. Scharton-Kersten, T., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1945. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330,
21. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis. and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725-3729.
22. Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, hut control parasite replication. J. Immunol. 157:827-835.
23. Wang, Z.-E., S. L. Reiner, F. Hatam, F. P. Heinzel, J. Bouvier, C. W. Turck, and R. M. Locksley. 1993. Targeted activation of CDS cells and infection of β2-microglobulin-deficient mice fail to confirm a primary protective role for CDS cells in experimental leishmaniasis. J. Immunol. 151:2077-2086.
24. Wei, X.-Q., I. G. Charles, A. Smith, J. Ure, G.-J. Feng, F.-P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.